نتائج البحث

Regorafenib with immunotherapy versus regorafenib alone as second‐line treatment for hepatocellular carcinoma: A multicenter real‐world study.

• Authors : Qiao, Liang^1,2 (AUTHOR); He, Wei^1,2 (AUTHOR); Wang, Guoying^3,4 (AUTHOR)

• Source: Cancer Medicine. May2024, Vol. 13 Issue 9, p1-13. 13p.

تفاصيل العنوان

CircDCAF8 promotes the progression of hepatocellular carcinoma through miR-217/NAP1L1 Axis, and induces angiogenesis and regorafenib resistance via exosome-mediated transfer.

• Authors : Gong, Jiahao^1,2 (AUTHOR); Han, Guoyong^1,2 (AUTHOR); Chen, Zhiqiang^1,2 (AUTHOR)

• Source: Journal of Translational Medicine. 5/30/2024, Vol. 22, p1-20. 20p.

تفاصيل العنوان

A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy.

• Authors : Gambaro, Karen^1,2,3 (AUTHOR) ; Marques, Maud^1,3 (AUTHOR) ; McNamara, Suzan^1,2 (AUTHOR)

Subjects: *COLORECTAL cancer; *METASTASIS; *REGORAFENIBCANADA

• Source: International Journal of Molecular Sciences. Jan2024, Vol. 25 Issue 1, p43. 23p.

تفاصيل العنوان

Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial–Mesenchymal Transition and Stemness Properties.

• Authors : Kuan, Feng-Che^1,2 (AUTHOR) ; Li, Jhy-Ming³ (AUTHOR) ; Huang, Yun-Ching^4,5 (AUTHOR)

Subjects: *EPITHELIAL-mesenchymal transition; *BLADDER cancer; *CISPLATIN

• Source: International Journal of Molecular Sciences. Dec2023, Vol. 24 Issue 24, p17610. 14p.

تفاصيل العنوان

Exploring Regorafenib Responsiveness and Uncovering Molecular Mechanisms in Recurrent Glioblastoma Tumors through Longitudinal In Vitro Sampling.

• Authors : Morelli, Mariangela¹ (AUTHOR) ; Lessi, Francesca¹ (AUTHOR) ; Franceschi, Sara¹ (AUTHOR)

• Source: Cells (2073-4409). Mar2024, Vol. 13 Issue 6, p487. 19p.

تفاصيل العنوان

Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.

• Authors : Taşçı, Elif Şenocak¹ (AUTHOR) ; Oyan, Başak² (AUTHOR); Sönmez, Özlem² (AUTHOR)

• Source: BMC Cancer. 1/22/2024, Vol. 24 Issue 1, p1-10. 10p.

تفاصيل العنوان

Comparative MIP sensor technique: photopolymerization or thermal polymerization for the sensitive determination of anticancer drug Regorafenib in different matrixes.

• Authors : Kaya, S. Irem¹ (AUTHOR); Bakirhan, Nurgul K.¹ (AUTHOR); Corman, M. Emin² (AUTHOR)

Subjects: *PHOTOPOLYMERIZATION; *ANTINEOPLASTIC agents; *POLYMERIZATION

• Source: Microchimica Acta. Oct2023, Vol. 190 Issue 10, p1-11. 11p.

تفاصيل العنوان

Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients (NEXT-REGIRI)

• Source: A Randomized Phase III Trial Assessing a Regorafenib-irinotecan Combination (REGIRI) Versus Regorafenib Alone in Metastatic Colorectal

تفاصيل العنوان

Research progress of regorafenib in the treatment of colorectal cancer

• Authors : CHEN Yixuan; LEI Xuefen; ZHANG Meng

Subjects: colorectal cancer; regorafenib; vascular endothelial growth factor receptors

• Source: Zhongguo linchuang yanjiu, Vol 37, Iss 9, Pp 1319-1322 (2024)

تفاصيل العنوان

Real-world dosing of regorafenib and outcomes among patients with metastatic colorectal cancer: a retrospective analysis using US claims data

• Authors : Tanios Bekaii-Saab; Nasreen Khan; Helene Ostojic

Subjects: Real world; Dosing; Regorafenib

• Source: BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)

تفاصيل العنوان